Money for medication: financial incentives to improve medication adherence in assertive outreach

被引:46
作者
Claassen, Dirk [1 ]
Fakhoury, Walid K. [2 ]
Ford, Richard [3 ]
Priebe, Stefan [4 ]
机构
[1] East London & City Mental Hlth Trust, Assert Outreach & Rehabil, 150 Stratford High St, London E15 2NE, England
[2] Newham Ctr Mental Hlth, Acad Unit, London, England
[3] Assert OutreachTeam Newham, London, England
[4] Queen Mary Univ, Social Psychiat, London, England
来源
PSYCHIATRIC BULLETIN | 2007年 / 31卷 / 01期
关键词
D O I
10.1192/pb.31.1.4
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
AIMS AND METHOD Although financial incentives to improve treatment adherence have been found effective in various medical specialties, there are few systematic data on their use, ethical background and effectiveness in psychiatry. We explored the practice of and possible ethical problems associated with direct financial incentives to improve adherence in assertive outreach teams in England. We also report clinical observations of a money for medication scheme with five assertive outreach patients in East London. RESULTS None of the assertive outreach teams that responded to the survey (response rate 47%) uses financial incentives. Attitudes of team managers towards the practice were mostly negative, often regarding it as unethical. Specific concerns were related to possible coercion and a negative impact on the therapeutic relationship. Out of five patients studied, four accepted the offer of money and had improved adherence; three remained without hospital admission since entering the scheme. CLINICAL IMPLICATIONS Money for medication might be a non- coercive and effective option to achieve medication adherence in otherwise non-adherent assertive outreach patients. However, ethical issues need further exploration and controlled trials are required to establish the effectiveness.
引用
收藏
页码:4 / 7
页数:4
相关论文
共 23 条
[1]  
Bock NN, 2001, INT J TUBERC LUNG D, V5, P96
[2]   ENHANCING THE TREATMENT ATTENDANCE OF MENTALLY-ILL CHEMICAL ABUSERS [J].
CAREY, KB ;
CAREY, MP .
JOURNAL OF BEHAVIOR THERAPY AND EXPERIMENTAL PSYCHIATRY, 1990, 21 (03) :205-209
[3]  
COGSWELL SH, 1996, PL S SOC CL, P115
[4]   Consumer views of representative payee use of disability funds to leverage treatment adherence [J].
Elbogen, EB ;
Soriano, C ;
Van Dorn, R ;
Swartz, MS ;
Swanson, JW .
PSYCHIATRIC SERVICES, 2005, 56 (01) :45-49
[5]   Should we pay the patient? Review of financial incentives to enhance patient compliance [J].
Giuffrida, A ;
Torgerson, DJ .
BRITISH MEDICAL JOURNAL, 1997, 315 (7110) :703-707
[6]   Relapse prevention in schizophrenia with new-generation antipsychotics: A systematic review and exploratory meta-analysis of randomized, controlled trials [J].
Leucht, S ;
Barnes, TRE ;
Kissling, W ;
Engel, RR ;
Correll, C ;
Kane, JM .
AMERICAN JOURNAL OF PSYCHIATRY, 2003, 160 (07) :1209-1222
[7]  
LONGMAN, 2003, DICT CONT ENGLISH
[8]   Interventions to enhance patient adherence to medication prescriptions - Scientific review [J].
McDonald, HP ;
Garg, AX ;
Haynes, RB .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2002, 288 (22) :2868-2879
[9]   Mandated community treatment: Beyond outpatient commitment [J].
Monahan, J ;
Bonnie, RJ ;
Appelbaum, PS ;
Hyde, PS ;
Steadman, HJ ;
Swartz, MS .
PSYCHIATRIC SERVICES, 2001, 52 (09) :1198-1205
[10]   Use of leverage to improve adherence to psychiatric treatment in the community [J].
Monahan, J ;
Redlich, AD ;
Swanson, J ;
Robbins, PC ;
Appelbaum, PS ;
Petrila, J ;
Steadman, H ;
Swartz, M ;
Angell, B ;
McNiel, DE .
PSYCHIATRIC SERVICES, 2005, 56 (01) :37-44